Stocks · Health care · Biological Products, (No Diagnostic Substances)

Relay Therapeutics, Inc.

RLAY Clue Score52
United States Fiscal year ends December CIK 0001812364 Results filed 4 Nov 2026

What the insiders did Net selling

Insider
Date
Role
Action
Shares
Price
Amount
Thomas Catinazzo
28 Oct 2026
Chief Financial Officer
Sell
1,469
$18.62
$27.35K
Donald A Bergstrom
28 Oct 2026
President, R&D
Sell
2,252
$18.62
$41.93K
Peter Rahmer
28 Oct 2026
See remarks
Sell
753
$18.62
$14.02K

What was left out

Form 4 filings counted 5
Amendments (4/A) skipped 0
Filings about a different issuer 0
Unreadable filings 0
Joint filings 0
Sales on a Rule 10b5-1 plan 3
Sales straight out of an exercise 0
Sales at will 3
Transactions with no price 0
Shares from compensation/vesting 0
History held since 20 Jul 2020